Dec 21
|
Eli Lilly (LLY) Rises Yet Lags Behind Market: Some Facts Worth Knowing
|
Dec 21
|
Health Stocks Get Shot at Redemption After Ozempic-Fueled Losses
|
Dec 21
|
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
|
Dec 21
|
Will Eli Lilly's Emergency Diabetes Drug Give Amphastar Wings?
|
Dec 21
|
Eli Lilly cut to Outperform at Daiwa Securities: 4 big analyst cuts
|
Dec 20
|
2 Unstoppable Growth Stocks to Buy in 2024
|
Dec 20
|
These 2 Unstoppable Stocks Could Make You Richer in 2024 and Beyond
|
Dec 20
|
3 Top Dividend Stocks That Recently Hiked Their Payouts
|
Dec 19
|
Shipping Attacks, Weight Loss Wonder Drugs, Lilly Stock Analysis, Trading Apple
|
Dec 19
|
The Zacks Analyst Blog Highlights Novo Nordisk, Eli Lilly, Vertex Pharmaceuticals, Regeneron and GSK
|
Dec 18
|
Structure Plummets 43% After Trailing Lilly In Obesity Treatment
|
Dec 18
|
New Shakeup Hits Obesity Pills. Structure Rolls Out Disappointing Data.
|
Dec 18
|
5 Big Drug Stocks That May Continue to Outperform in 2024
|
Dec 18
|
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22, 2023
|
Dec 18
|
Point radiopharma drug results disappoint in prostate cancer study
|
Dec 15
|
Taylor Swift, X, AI, Disney, and more: Top stories of 2023
|
Dec 15
|
Eli Lilly (LLY) Dips More Than Broader Market: What You Should Know
|
Dec 15
|
Where Will Eli Lilly Be in 5 Years?
|
Dec 14
|
Elanco Animal Health CEO Targeted by Activist Investor Ancora
|
Dec 14
|
12 Best Growth Stocks to Buy Today According to Billionaire Ken Fisher
|